Dr. Adaeze Ekwe, PhD Junior Associate Editor, ISCT Telegraft Australia The first quarter of 2026 has been a pivotal period for the global cell and gene therapy (CGT) sector, defined by clinical milestones, regulatory reforms and the launch of next-generation manufacturing hubs. These...
Joaquim Vives, PhD Contributing Editor, ISCT Telegraft Ban de Sang i Teixits Spain The World, viewed through the lens of a microscope, is a place of a delicate elegance. We observe the migration of cells, the effect of cytokines or the kinetics in a validated assay. In the lab, we are...
Janet Macpherson, PhD Senior Editor, ISCT Telegraft Royal Prince Alfred Hospital Australia As 2026 bolts out of the blocks like a sprinter, the extremes of seasons (winter in Europe and summer in Australia) are tempered by the global perspective of the ISCT membership and Telegraft ...
Travis Byrd, PhD Junior Associate Editor, ISCT Telegraft The Ohio State University Wexner Medical Center United States Earlier this month, I attended a local immuno-oncology symposium as a representative of our cell therapy lab’s process development team. I presented a poster showcasing some...
Miguel Forte, MD, PhD President, ISCT MC4TX Belgium The value that cell and gene therapy can deliver to patients is incredibly significant, from potent efficacy to long term benefits and actual cures. Those working in the field know this, believe it, and often wonder why others still...
Travis Byrd, Ph.D The Ohio State University Wexner Medical Center Columbus, OH - USA Since the initial exploration of mesenchymal stromal cells (MSCs) for therapeutic use by Dr. Arnold Caplan’s group in 1995, hundreds of clinical trials have been...
Ashley Krull, Ph.D. Associate Director W.W. Williams Cellular Therapy Laboratory The Ohio State University Columbus, Ohio, USA One week ago, a new manuscript re-introduced the concept of CAR-MSCs and piqued the interest of immunologists and cell biologists afresh. The report,...
Adaeze Ekwe, PhD Junior Associate Editor ISCT ESP Leadership Development Program From the laboratories to the clinics and boardrooms, women have been integral to the progress made in cell and gene therapy. As such for this Women’s History Month and International Women’s Day we...
Wouter Van’t Hof, Contributing Editor Cleveland Cord Blood Center Cleveland OH, USA What’s in Your CGT Product? The shared responsibility of all of us cell and gene therapy developers involved with ISCT and with the ambition of bringing cell-based therapies to...
Janet Macpherson, PhD Cytiva Sydney, Australia Your Telegraft editorial team are dedicating this first issue of 2024 to a reflection of 2023 content and highlights. Please do take the opportunity to catch up on articles that you may have missed during the busy year that...